Xuefei Wang, MD, PhD
Zhongshan Hospital, Fudan University, Shanghai, China. · Fudan University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Xuefei Wang, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:58 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07257380 · Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment: An Adaptive Trial (MRD-ATLAS)Shanghai Zhongshan Hospital · not yet recruiting · Gastric / Gastroesophageal Junction Adenocarcinoma · principal investigator
- Ph2NCT06468280 · Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in Patients With Limited-metastatic Gastric CancerShanghai Zhongshan Hospital · recruiting · Gastric Cancer, GastroEsophageal Cancer · principal investigator
- Ph2NCT04799548 · A Phase II Study of TACE Plus PD-1 Antibody in the Locally Advanced Stomach AdenocarcinomaShanghai Zhongshan Hospital · unknown · Advanced Gastric Cancer · principal investigator
- Ph3NCT03680261 · Enriched-CRT 2017: Advanced Gastric Cancer With LN+ and LVI+, Chemotherapy vs. ChemoradiotherapyShanghai Zhongshan Hospital · unknown · Gastric Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:58 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.